Gyeonggi-do, South Korea

Su Bong Cha

This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Sk Biopharmaceuticals Co., Ltd.. Active years: 2014-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Su Bong Cha. Retrieved from https://idiyas.com/inventor/su-bong-cha

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0


 

Average Co-Inventor Count = 6.2

ph-index = 3

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2014-2019

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Su Bong Cha in Pharmaceutical Composition

Introduction

Su Bong Cha is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that address cognitive disorders. With a total of 5 patents to his name, Cha's work is recognized for its potential impact on medical treatments.

Latest Patents

Cha's latest patents focus on pharmaceutical compositions comprising pyridone derivatives. These patents detail a pyridone derivative compound along with a pharmaceutically acceptable salt, isomer, solvate, or hydrate thereof. The compositions are designed for preventive or therapeutic applications in cognitive disorders, showcasing the innovative nature of his research.

Career Highlights

Cha is currently associated with Sk Biopharmaceuticals Co., Ltd., where he continues to advance his research in pharmaceuticals. His work is characterized by a commitment to developing effective treatments that can improve cognitive health.

Collaborations

Some of his notable coworkers include Cheol Young Maeng and Young Koo Jang, who contribute to the collaborative efforts in their research projects.

Conclusion

Su Bong Cha's innovative work in pharmaceutical compositions highlights his dedication to addressing cognitive disorders through advanced research. His contributions are paving the way for future developments in the field of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…